Trial Profile
Clinical Trials Insight: 700053470
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Feb 2010
Price :
$35
*
At a glance
- Drugs Gemigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors LG Life Sciences
- 11 Feb 2010 New trial record.
- 01 Dec 2009 Results published in the British Journal of Clinical Pharmacology.